teclistamab,bortezomib,lenalidomide,dexamethasone,daratumumab
janssen,genmab,takeda
 = luciano costa discussed mrd based treatment strategies in ndmm and presented his master2 trial integrating teclistamab and investigating the role of asct in mrd- patients #ims2022 
Director of the Multiple Myeloma and Amyloidosis Service @columbiacancer - Associate Editor @JCO_ASCO - Tweets are my own